Continuous subcutaneous apomorphine monotherapy in Parkinson's disease
{{output}}
Introduction and objective: Continuous subcutaneous apomorphine (APO) treatment is one of the 3 therapeutic options for advanced Parkinson's disease (PD), in addition to deep brain stimulation (DBS) and intrajejunal levodopa. Dat... ...
